Fluence Training Provides Top-Flight Therapists For Tryp Therapeutics’ Phase 2a For Eating Disorder
Sep 9, 2021
View More
Tryp Therapeutics Investor Day - July 2021
Aug 3, 2021
Oren Klaff Talks to Greg Mckee on Dealmaking in the Psychedelics Space
Aug 2, 2021
View More
TraderTV Live Interview with Greg Mckee, Chairman & CEO of Tryp Therapeutics
Jul 22, 2021
View More
Podcast Interview: OTC Markets
May 26, 2021
View More
TRYP Q1 Investor Day (Video)
May 25, 2021
View More
Is the Psychedelic Industry Following in the Footsteps of GW Pharma?
May 20, 2021
View More
6 Keys to Leadership Growth
May 13, 2021
View More
Fireside Chat: Jim Gilligan & Dr. Jennifer Miller
May 5, 2021
View More
Tryp CEO, Greg McKee Featured on Entrepreneur.com (PODCAST)
May 3, 2021
View More
Report on Psychedelics - Different Drug, Different Path
Mar 31, 2021
View More
PSYCHEDELIC FINANCE - Dr. Robin Carhart-Harris | Scientific Advisory Board, Tryp Therapeutics
Mar 10, 2021
View More
The Truffle Report - Interview with James Gilligan, President
Mar 8, 2021
View More
VIDEO - TRYP Therapeutics Commences Trading on the CSE
Dec 18, 2020
FORBES - Psilocybin Could Be The Next Star In Functional Food After Cannabis As Public Interest Heats Up
Dec 17, 2020
View More
US MONEY NEWS - Why Investing in Psychedelic Medicine Could Be Better Than Cannabis
Oct 20, 2020
View More
